Tocopherol enriched compositions and amelioration of inflammatory symptoms

Details for Australian Patent Application No. 2002327517 (hide)

Owner Johnson & Johnson Consumer Companies, Inc.

Inventors Phinney, Stephen Dodge; Brown, Lesley; Flaim, Stephen; Dreon, Darlene M.; Miller, Guy; Beinlich, Peggy; Boddupalli, Sekhar

Agent Davies Collison Cave

Pub. Number AU-B-2002327517

PCT Number PCT/US02/26920

PCT Pub. Number WO2003/015494

Priority 60/314,257 21.08.01 US; 60/314.223 21.08.01 US; 60/314,256 21.08.01 US

Filing date 21 August 2002

Wipo publication date 3 March 2003

Acceptance publication date 17 April 2008

International Classifications

A61K 31/335 (2006.01) - having oxygen as the only ring hetero atom, e.g. fungichromin

A61K 31/355 (2006.01)

A61P 1/02 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

23 January 2003 Complete Application Filed

  Priority application(s): 60/314,257 21.08.01 US; 60/314.223 21.08.01 US; 60/314,256 21.08.01 US

29 May 2003 Application Open to Public Inspection

  Published as AU-B-2002327517

15 July 2004 Change of Name(s) of Applicant(s), Section 104

  Galileo Laboratories, Inc. The name of the applicant has been changed to Galileo Pharmaceuticals, Inc. 2003

29 March 2007 Assignment before Grant

  Galileo Pharmaceuticals, Inc. The application has been assigned to Johnson & Johnson Consumer Companies, Inc.

17 April 2008 Application Accepted

  Published as AU-B-2002327517

14 August 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002327518-Space-based network architectures for satellite radiotelephone systems

2002327516-FRAMEWORKS FOR EFFICIENT REPRESENTATION OF STRING OBJECTS IN JAVA PROGRAMMING ENVIRONMENTS